The Department of Health and Human Services today proposed to withdraw a rule finalized in January that requires the agency to periodically assess each regulation to determine whether it has a significant economic impact on a substantial number of small entities, and if so review the regulation to determine whether to retain, modify or eliminate it. Under this final rule, which was set to take effect in March 2022, a regulation expires if the agency fails to assess and review it in a timely manner, with certain exceptions such as rules issued jointly with other agencies. Comments on the proposal to withdraw the finalized rule will be accepted for 60 days. 
 
AHA last year urged HHS to withdraw the rule, saying it “does not provide an adequate mechanism for obtaining public input on the substance of regulations being reviewed.” 
 

Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…
Headline
The AHA March 24 commented to the Centers for Medicare & Medicaid Services on upcoming requirements from the Consolidated Appropriations Act of 2026…
Headline
The AHA Feb. 27 shared recommendations on the Health Data, Technology and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity proposed rule,…
Headline
The AHA today submitted a letter to the Office of Science and Technology Policy in response to its request for information on regulatory reform for artificial…
Headline
The AHA and Federation of American Hospitals Aug. 8 filed an amicus brief in the U.S. District Court for the Eastern District of Texas in support of the U.S.…
Headline
President Trump Aug. 7 issued an executive order, “Improving Oversight of Federal Grantmaking,” requiring government agencies to review new and discretionary…